See more : Accretion Acquisition Corp. (ENER) Income Statement Analysis – Financial Results
Complete financial analysis of Patient Access Solutions, Inc. (PASO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Patient Access Solutions, Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- NeoGenomics, Inc. (NEO) Income Statement Analysis – Financial Results
- Osteopore Limited (OSX.AX) Income Statement Analysis – Financial Results
- Bone Biologics Corporation (BBLGW) Income Statement Analysis – Financial Results
- Inovio Pharmaceuticals, Inc. (INO) Income Statement Analysis – Financial Results
- MH Ethanol Co.,Ltd. (023150.KS) Income Statement Analysis – Financial Results
Patient Access Solutions, Inc. (PASO)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.pashealth.com
About Patient Access Solutions, Inc.
Patient Access Solutions, Inc. provides healthcare/financial processing solutions for the healthcare and dental industries. The company, through its merchant processing platform, provides patient eligibility, medical billing, and patient self-pay solutions. It also provides practice management, business management consulting, GAP analysis, and marketing and practice development services; and treatment services for autism, concussion, PTSD, and other biomedical conditions, as well as diagnostic testing services. Patient Access Solutions, Inc. is based in Plainview, New York.
Metric | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
---|---|---|---|---|---|---|
Revenue | 212.74K | 504.14K | 937.81K | 1.86M | 2.46M | 650.93K |
Cost of Revenue | 0.00 | 0.23 | 2.78K | -2.78K | 45.54K | 0.00 |
Gross Profit | 212.74K | 504.14K | 935.03K | 1.86M | 2.41M | 650.93K |
Gross Profit Ratio | 100.00% | 100.00% | 99.70% | 100.15% | 98.15% | 100.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 1.42K | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 66.23 | 0.00 |
SG&A | 9.18M | 7.51M | 467.25K | 1.12M | 3.80M | 540.09K |
Other Expenses | -14.59K | -680.00 | 60.00 | -9.54K | 0.00 | 0.00 |
Operating Expenses | 9.19M | 7.51M | 467.19K | 1.13M | 3.80M | 540.09K |
Cost & Expenses | 9.22M | 7.51M | 467.19K | 1.13M | 3.84M | 540.09K |
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 57.41 | 13.64 |
Interest Expense | 2.77K | 400.00 | 1.33K | 27.24K | 0.00 | 0.00 |
Depreciation & Amortization | 23.50K | 206.30K | 171.86K | 0.00 | 45.54K | -20.17 |
EBITDA | -12.10M | -7.34M | 470.62K | 726.34K | -1.45M | 110.80K |
EBITDA Ratio | -5,687.04% | -1,389.17% | 50.18% | 39.09% | -54.43% | 0.00% |
Operating Income | -9.00M | -7.00M | 470.62K | 726.43K | -1.38M | 110.84K |
Operating Income Ratio | -4,232.52% | -1,389.17% | 50.18% | 39.09% | -56.28% | 17.03% |
Total Other Income/Expenses | -1.59M | -333.05K | -1.27K | -27.33K | -190.40K | -1.57K |
Income Before Tax | -10.59M | -7.34M | 469.35K | 699.10K | -1.57M | 109.27K |
Income Before Tax Ratio | -4,979.71% | -1,455.24% | 50.05% | 37.62% | -64.03% | 16.79% |
Income Tax Expense | -1.53M | -206.30K | -171.86K | 0.00 | 4.00 | -110.83K |
Net Income | -10.59M | -7.34M | 469.35K | 699.10K | -1.57M | 109.27K |
Net Income Ratio | -4,979.71% | -1,455.24% | 50.05% | 37.62% | -64.03% | 16.79% |
EPS | 0.00 | -0.01 | 0.00 | 0.00 | -0.02 | 0.00 |
EPS Diluted | 0.00 | -0.01 | 0.00 | 0.00 | -0.02 | 0.00 |
Weighted Avg Shares Out | 2.28B | 1.16B | 389.75M | 268.21M | 81.52M | 24.52M |
Weighted Avg Shares Out (Dil) | 2.28B | 1.16B | 389.75M | 0.00 | 81.52M | 24.52M |
Patient Access Solutions Has Opened and is Managing New Center in Long Island, N.Y.
Update: Patient Access Solutions, Hestia Insight, and US Stem Cell to Form Business Consortium
Patient Access Solutions, Hestia Insight, and US Stem Cell to Form Business Consortium
Shareholder Update
Patient Access Solutions to Open and Manage New Facility in Long Island, N.Y.
Source: https://incomestatements.info
Category: Stock Reports